RA-led $35M round clears path for Cerebral’s epilepsy Phase II

Cerebral is looking to take its epilepsy drug delivery system into an international trial after proof-of-concept data for CT-010 enabled the company to raise a tranched

Read the full 269 word article

User Sign In